Apatinib-treated advanced medullary thyroid carcinoma: a case report

Medullary thyroid carcinoma (MTC) is a rare malignancy originating from calcitonin-producing parafollicular C cells of the thyroid. Neither radiotherapy nor chemotherapy has demonstrated durable objective responses in patients with advanced MTC. Vandetanib and cabozantinib are the 2 tyrosine kinase...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Kan, Gao, Yun, Shi, Fei, Cao, Guangqiang, Bao, Jiandong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783142/
https://www.ncbi.nlm.nih.gov/pubmed/29403290
http://dx.doi.org/10.2147/OTT.S142598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783142/
https://www.ncbi.nlm.nih.gov/pubmed/29403290
http://dx.doi.org/10.2147/OTT.S142598

Ejemplares similares